BRIEF published on 03/27/2025 at 19:17, 2 months 22 days ago Advicenne Reports Solid Growth and Future Plans for 2025 Cash Flow Improvement 2025 Outlook Advicenne Financial Results Sibnayal Sales Growth ADV7103 Regulatory Progress
BRIEF published on 03/27/2025 at 19:17, 2 months 22 days ago Advicenne annonce une croissance solide et des projets futurs pour 2025 Amélioration Des Flux De Trésorerie Perspectives 2025 Résultats Financiers D'Advicenne Croissance Des Ventes De Sibnayal Progrès Réglementaires ADV7103
PRESS RELEASE published on 03/27/2025 at 19:12, 2 months 22 days ago Inside Information / News release on accounts, results Advicenne reports successful commercial performance of Sibnayal® in Europe, with total product sales up 9.4% to €4.9m. Major strides in US development with NDA filing expected in Q3 2025 Financial Results Advicenne Commercial Performance Sibnayal US Development
PRESS RELEASE published on 03/27/2025 at 19:12, 2 months 22 days ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne annonce ses résultats annuels 2024 avec un chiffre d'affaires en hausse de 9,4% grâce à Sibnayal® en Europe; avancées réglementaires majeures aux Etats-Unis Chiffre D'affaires Résultats Annuels États-Unis Advicenne Sibnayal
BRIEF published on 10/01/2024 at 07:05, 8 months 17 days ago Advicenne progresse aux États-Unis avec des avis positifs de la FDA sur ADV7103 FDA Advicenne ADV7103 ATRd Cystinurie
BRIEF published on 10/01/2024 at 07:05, 8 months 17 days ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 8 months 17 days ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
PRESS RELEASE published on 10/01/2024 at 07:00, 8 months 17 days ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 1 year 1 month ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
BRIEF published on 05/15/2024 at 09:07, 1 year 1 month ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
Published on 06/18/2025 at 23:15, 2 hours 4 minutes ago Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 06/18/2025 at 23:05, 2 hours 14 minutes ago Faraday Copper Announces Annual General Meeting Voting Results
Published on 06/18/2025 at 22:30, 2 hours 49 minutes ago Grande Portage Resources Confirms Non-Brokered Private Placement Finder Fees
Published on 06/18/2025 at 22:25, 2 hours 54 minutes ago Bird River Announces Closing of Tranche of Common Share Financing for Gross Proceeds of Approximately $312,000
Published on 06/18/2025 at 15:15, 10 hours 4 minutes ago Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
Published on 06/18/2025 at 21:33, 3 hours 46 minutes ago Sartorius Stedim Biotech SA: Michael Grosse, nouveau CEO de Sartorius AG, devient Président du Conseil d'administration de Sartorius Stedim Biotech S.A.
Published on 06/18/2025 at 21:33, 3 hours 46 minutes ago Sartorius Stedim Biotech SA: Incoming Sartorius CEO Michael Grosse to become Chairman of the Board of Sartorius Stedim Biotech S.A.
Published on 06/18/2025 at 19:34, 5 hours 45 minutes ago Kontron and congatec sign term sheet on congatec's investment in JUMPtec
Published on 06/18/2025 at 19:16, 6 hours 2 minutes ago EQS-Adhoc: Medios adopts public share buyback offer for up to 1 million shares at a price of EUR 12.50
Published on 06/18/2025 at 19:07, 6 hours 11 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 06/18/2025 at 18:00, 7 hours 19 minutes ago Saint-Gobain enhances its digital construction chemicals platform with the acquisition of Maturix
Published on 06/18/2025 at 18:00, 7 hours 19 minutes ago Saint-Gobain renforce son offre digitale dans la chimie de la construction avec l’acquisition de Maturix
Published on 06/18/2025 at 17:45, 7 hours 34 minutes ago COGELEC : Compte rendu de l’Assemblée Générale Mixte du 4 juin 2025.
Published on 06/18/2025 at 17:45, 7 hours 34 minutes ago Frédéric Chevalier appointed CEO of Lagardère Travel Retail, alongside Dag Rasmussen, effective 1st July, 2025
Published on 06/18/2025 at 17:45, 7 hours 34 minutes ago Frédéric Chevalier est nommé Directeur Général de Lagardère Travel Retail aux côtés de Dag Rasmussen, à compter du 1er juillet 2025.
